Approval · Notice of Compliance 10913 · 2010
ORGARAN: Notice of Compliance 10913
Issued January 12, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10913
- Date
- January 12, 2010
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anticoagulant / Antithrombotic agent (heparinoid)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORGARAN | 02129043 | Marketed |
Medicinal ingredients
- DANAPAROID SODIUM 750 UNIT per 0.6ML